UB Paderborn / Katalog / Suche / in CDI

3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy

Cancer research (Chicago, Ill.), 2017-08, Vol.77 (15), p.4171-4184

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4167: Snai2(Slug) regulates tumor angiogenesis through the induction of EndoMT

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4167-4167

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5500: A 3D tumor tissue microphysiological system for realistic tumor microenvironment mimicry and therapeutic modeling

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.5500-5500

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5228: mTORC2 mediates SDF-1α/CXCL12-induced angiogenesis

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.5228-5228

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS18-06: Proteomic analysis of breast cancer formalin-fixed paraffin-embedded clinical specimens identifies biologically-important subtypes with distinct clinical outcomes

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS18-06-PS18-06

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract PR002: Identification of metabolic adaptation mechanisms that drive anoikis suppression and metastasis in Ewing sarcoma

Cancer research (Chicago, Ill.), 2023-01, Vol.83 (2_Supplement_2), p.PR002-PR002

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract A024: A potent eIF4A1/2 inhibitor CR-1-31B down-modulates the antioxidant stress response in osteosarcoma cells and inhibits in vivo lung metastases

Cancer research (Chicago, Ill.), 2023-01, Vol.83 (2_Supplement_2), p.A024-A024

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 14: Drug sensitivity of vascularized tumor tissue in vitro

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.14-14

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5116: Phosphatidylserine-targeting antibodies augment anti-tumor activity of PD-1 antibodies and alter immuno-profiles in murine triple negative breast cancers

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.5116-5116

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2593: A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2593-2593

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3930: Recapitulating the microenvironment in vitro for comparative study of factors affecting tumor growth and vascularization

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3930-3930

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2850: Predicting anti-tumor responses to phosphatidylserine targeting antibodies using tumor imaging

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2850-2850

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4880: Monitoring tumor response to chemotherapy by in vivo real-time imaging of phosphatidylserine targeting antibodies

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4880-4880

2011

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2452: Tumor detection and measurement of responses to chemotherapy using human phosphatidylserine targeting antibody fragments

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2452-2452

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2510: Increased Fc-FcR interaction of human phosphatidylserine targeting antibody enhances pro-inflammatory and ADCC anti-tumor mechanisms

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2510-2510

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2454: In vivo binding of chTNT-1/B antibodies (Cotara) to DNA/histone complexes in tumors using near-infrared optical imaging

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2454-2454

2012

Link zum Volltext

Verfügbarkeit prüfen

ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance

Cancer research (Chicago, Ill.), 2022-12, Vol.82 (24), p.4571-4585

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-08-01: Clonal hematopoiesis of indeterminate potential (CHIP) in metastatic triple negative breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-08-01

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB227: Automated image registration and alignment facilitates assessment of change in pigmented lesions of patients at risk for melanoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.LB227-LB227

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2417: Mutant p53 and oncogenic KRAS converge on CREB1 to drive pancreatic cancer metastasis

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2417-2417

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract OT3-17-01: OPTIMA: A prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in mostly node-positive early breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.OT3-17-01-OT3-17-01

2020

Link zum Volltext

Verfügbarkeit prüfen

Metastatic Progression with Resistance to Aromatase Inhibitors Is Driven by the Steroid Receptor Coactivator SRC-1

Cancer research (Chicago, Ill.), 2012-01, Vol.72 (2), p.548-559

2012

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-01-03: Ultrasensitive detection of minimal residual disease in patients treated for breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-01-03

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4720: Ataxia telangiectasia mutated (ATM) kinase inhibitor AZD0156 in combination with 5-fluorouracil and irinotecan in preclinical models of colorectal cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4720-4720

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5676: Digital spatial profiling for determination of pancreatic stromal components and correlation with survival

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.5676-5676

2022

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy

Abstract 4167: Snai2(Slug) regulates tumor angiogenesis through the induction of EndoMT

Abstract 5500: A 3D tumor tissue microphysiological system for realistic tumor microenvironment mimicry and therapeutic modeling

Abstract 5228: mTORC2 mediates SDF-1α/CXCL12-induced angiogenesis

Abstract PS18-06: Proteomic analysis of breast cancer formalin-fixed paraffin-embedded clinical specimens identifies biologically-important subtypes with distinct clinical outcomes

Abstract PR002: Identification of metabolic adaptation mechanisms that drive anoikis suppression and metastasis in Ewing sarcoma

Abstract A024: A potent eIF4A1/2 inhibitor CR-1-31B down-modulates the antioxidant stress response in osteosarcoma cells and inhibits in vivo lung metastases

Abstract 14: Drug sensitivity of vascularized tumor tissue in vitro

Abstract 5116: Phosphatidylserine-targeting antibodies augment anti-tumor activity of PD-1 antibodies and alter immuno-profiles in murine triple negative breast cancers

Abstract 2593: A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma

Abstract 3930: Recapitulating the microenvironment in vitro for comparative study of factors affecting tumor growth and vascularization

Abstract 2850: Predicting anti-tumor responses to phosphatidylserine targeting antibodies using tumor imaging

Abstract 4880: Monitoring tumor response to chemotherapy by in vivo real-time imaging of phosphatidylserine targeting antibodies

Abstract 2452: Tumor detection and measurement of responses to chemotherapy using human phosphatidylserine targeting antibody fragments

Abstract 2510: Increased Fc-FcR interaction of human phosphatidylserine targeting antibody enhances pro-inflammatory and ADCC anti-tumor mechanisms

Abstract 2454: In vivo binding of chTNT-1/B antibodies (Cotara) to DNA/histone complexes in tumors using near-infrared optical imaging

ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance

Abstract P3-08-01: Clonal hematopoiesis of indeterminate potential (CHIP) in metastatic triple negative breast cancer

Abstract LB227: Automated image registration and alignment facilitates assessment of change in pigmented lesions of patients at risk for melanoma

Abstract 2417: Mutant p53 and oncogenic KRAS converge on CREB1 to drive pancreatic cancer metastasis

Abstract OT3-17-01: OPTIMA: A prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in mostly node-positive early breast cancer

Metastatic Progression with Resistance to Aromatase Inhibitors Is Driven by the Steroid Receptor Coactivator SRC-1

Abstract P5-01-03: Ultrasensitive detection of minimal residual disease in patients treated for breast cancer

Abstract 4720: Ataxia telangiectasia mutated (ATM) kinase inhibitor AZD0156 in combination with 5-fluorouracil and irinotecan in preclinical models of colorectal cancer

Abstract 5676: Digital spatial profiling for determination of pancreatic stromal components and correlation with survival

Aktive Filter

Suchergebnisse filtern